hidden pixel

Methoxetamine Information

Methoxetamine (MXE) or 3-MeO-2-Oxo-PCE is a chemical of the arylcyclohexylamine class which has been sold as a designer drug.[1] It is a derivative of ketamine that also contains structural features of eticyclidine and 3-MeO-PCP. Methoxetamine is thought to behave as a NMDA receptor antagonist and dopamine reuptake inhibitor, though it has not been formally profiled pharmacologically.[2] Methoxetamine differs from many other dissociative anesthetics of the arylcyclohexylamine class in that it was designed for grey market distribution.[3] Methoxetamine is a product of rational drug design: its N-ethyl group was chosen to increase potency.[3]

Contents

Emergence

The European Monitoring Centre for Drugs and Drug Addiction, which monitors the internet for new psychoactive substances within the European Union, first identified methoxetamine in November 2010.[1] By July 2011, they had identified 58 websites selling the compound, at a cost of 145–195 euros for 10 grams.[4]

Effects

It is reported to have similar desirable and unwanted effects to ketamine, although some users have reported that the unwanted effects last longer than for ketamine.[5] Nothing is known about the potential toxicity of methoxetamine, but people have been hospitalized in the US and UK after using it recreationally.[2][6] It has been marketed as "bladder friendly", referencing the bladder damage associated with chronic ketamine use, but further scientific research is required to determine whether this is the case.[6][7] From the limited information available based on user reports on internet discussion forums, toxicologists have stated it has "potential to be associated with significant acute harm/toxicity if used as a recreational drug."[5]

Legal status

Methoxetamine powder

Media coverage

Mixmag reported in January 2012, that people in the dance music and clubbing community have given methoxetamine the slang name 'roflcoptr'.[13] Vice commented that it was likely that the phrase will only be used by "the same politicians, parents and journalists" who called mephedrone 'meow meow'.[14]

On march 6th 2012, methoxetamine has been referred to the UK parliament's drugs advisers in a bid to impose a temporary banning order. The Advisory Council on the Misuse of Drugs (ACMD) has up to 20 working days to recommend whether the substance should be banned under a temporary drug class order, which would see it made illegal for 12 months. If banned, the advisers would then consider whether it should be placed under permanent control under the Misuse of Drugs Act 1971. [15]

A literature review was published in March 2012 which looked at scientific literature and information on the web. It concluded that "the online availability of information on novel psychoactive drugs, such as methoxethanine, may constitute a pressing public health challenge. Better international collaboration levels and novel forms of intervention are necessary to tackle this fast-growing phenomenon."[16]

See also

References

  1. ^ a b c EMCDDA Annual Report 2010 (Report). European Monitoring Centre for Drugs and Drug Addiction. 2010. http://www.emcdda.europa.eu/attachements.cfm/att_132857_EN_EMCDDA-Europol%20Annual%20Report%202010A.pdf. Retrieved 2012-01-23.
  2. ^ a b Ward, J.; Rhyee, S.; Plansky, J. (2011). "Methoxetamine: A novel ketamine analog and growing health-care concern". Clinical Toxicology: 1. doi:10.3109/15563650.2011.617310.
  3. ^ a b Morris, H. (2011-02-11). "Interview with a ketamine chemist: or to be more precise, an arylcyclohexylamine chemist". Vice Magazine. http://www.viceland.com/int/v18n2/htdocs/interview-with-ketamine-chemist-704.php?page=1. Retrieved 2012-01-23.
  4. ^ Online sales of new psychoactive substances/‘legalhighs’: Summary of results from the 2011 multilingual snapshots (Report). European Monitoring Centre for Drugs and Drug Addiction. 2011-11-15. http://www.emcdda.europa.eu/attachements.cfm/att_143801_EN_SnapshotSummary.pdf. Retrieved 2012-01-23.
  5. ^ a b Wood, D. M.; Davies, S.; Calapis, A.; Ramsey, J.; Dargan, P. I. (2011). "Novel drugs--novel branding". QJM. doi:10.1093/qjmed/hcr191.
  6. ^ a b Wood, DM; Davies, S, Puchnarewicz, M, Johnston, A, Dargan, PI (2011). "Acute toxicity associated with the recreational use of the ketamine derivative methoxetamine.". European journal of clinical pharmacology. PMID 22205276.
  7. ^ Max Daly and Peter Simonson (November 2011). "Street drug trends survey 2011". Drugscope. http://www.drugscope.org.uk/Resources/Drugscope/Documents/PDF/Publications/StreetDrugsSurvey2011.pdf. Retrieved 2012-01-03.
  8. ^ Poppy McPherson (2012-02-13). "Health alert over drug sold as 'safe ketamine'". The Independent. http://www.independent.co.uk/life-style/health-and-families/health-news/health-alert-over-drug-sold-as-safe-ketamine-6804824.html. Retrieved 2012-02-18.
  9. ^ "Resolution of the Government of the Russian Federation on October 6, 2011 N 822". http://www.rg.ru/2011/10/19/narko-dok.html. Retrieved 2012-02-20. (Russian)
  10. ^ "Ordinance on the lists of narcotic drugs, psychotropic substances, precursors and auxiliary chemicals". http://www.admin.ch/dokumentation/gesetz/00068/index.html?lang=de&download=NHzLpZeg7t,lnp6I0NTU042l2Z6ln1acy4Zn4Z2qZpnO2Yuq2Z6gpJCDeHx2gWym162epYbg2c_JjKbNoKSn6A--. Retrieved 2012-02-20. (German)
  11. ^ http://www.homeoffice.gov.uk/media-centre/news/mexxy
  12. ^ http://www.homeoffice.gov.uk/publications/alcohol-drugs/drugs/methoxetamine-referral
  13. ^ Beaumont-Thomas, Ben (2012-01-18). "Methoxetamine is a new chemical analogue of ketamine. It's legal, it's cheap and it's trippy as hell - but is it safe?". London, UK: Mixmag. p. 60.
  14. ^ Alex Miller (2011-02-11). "We Interviewed the Inventor of Roflcoptr, the New Drug Britain's Panicking About". Vice Magazine. http://www.vice.com/en_uk/read/we-interviewed-the-man-who-invented-roflecoptr. Retrieved 2011-02-11.
  15. ^ . http://www.independent.co.uk/life-style/health-and-families/health-news/bid-to-ban-safe-drug-methoxetamine-after-deaths-7542175.html.
  16. ^ Corazza, O.; Schifano, F.; Simonato, P.; Fergus, S.; Assi, S.; Stair, J.; Corkery, J.; Trincas, G. et al (2012). "Phenomenon of new drugs on the Internet: The case of ketamine derivative methoxetamine". Human Psychopharmacology: Clinical and Experimental 27 (2): 145. doi:10.1002/hup.1242.

External links

Wikimedia Commons has media related to: Methoxetamine
Recreational drug use
Major recreational drugs
Opioids
Depressants
Stimulants
Entactogens
Hallucinogens
Psychedelics
Dissociatives
Deliriants
Cannabinoids
Oneirogens
Drug subculture
Cannabis
Psychedelic
Other
Problems with drug use
Legality of drug use
International
State level
Drug policy by country
Other
  • Arguments for and against drug prohibition
  • Capital punishment for drug trafficking
  • Designer drug
  • Drug court
  • Drug possession
  • Drug test
  • Hard and soft drugs
  • Illegal drug trade in Colombia
  • Mexican Drug War
  • Narc
  • Opium production in Afghanistan
  • Politics of drug abuse
  • War on Drugs
  • Zero tolerance
Lists of countries by...
Entheogens (hallucinogens)
Psychedelics 5-HT2AR agonists
Dissociatives NMDAR antagonists
Deliriants mAChR antagonists
Miscellaneous
Cannabinoids CB1R agonists
D2R agonists

* Also indirect D2 agonists such as dopamine reuptake inhibitors (cocaine

GABAAR agonists
Inhalants Mixed MOA
κOR agonists
σR agonists
Others

Categories:

 

The above information uses material from Wikipedia and is licensed under the GNU Free Documentation License.
Some facts may not have been fully verified for accuracy. [Disclaimers]
This page was last archived by our server on Sat Mar 17 14:24:16 2012.
Displaying this page or its contents does not use any Wikimedia Foundation's resources.
The owners of this site proudly support the Wikimedia Foundation.